Heart Valve Repair And Replacement Devices Market

By Product;

Heart Valve Replacement Devices and Heart Valve Repair Devices

By Surgery;

Minimally Invasive Surgeries, Transcatheter Surgeries, and Open Surgeries

By Indication;

Valvular Stenosis, Valvular Insufficiency, Mitral Valve Prolapse, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn444647206 Published Date: August, 2025

Heart Valve Repair and Replacement Devices Overview

Heart Valve Repair and Replacement Devices Market (USD Million)

Heart Valve Repair and Replacement Devices Market was valued at USD 8,347.90 million in the year 2024. The size of this market is expected to increase to USD 19,039.04 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 12.5%.


Heart Valve Repair And Replacement Devices Market

*Market size in USD million

CAGR 12.5 %


Study Period2025 - 2031
Base Year2024
CAGR (%)12.5 %
Market Size (2024)USD 8,347.90 Million
Market Size (2031)USD 19,039.04 Million
Market ConcentrationLow
Report Pages388
8,347.90
2024
19,039.04
2031

Major Players

  • Edwards Lifesciences Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • LivaNova PLC
  • CryoLife, Inc.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Micro Interventional Devices, Inc.

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Heart Valve Repair And Replacement Devices Market

Fragmented - Highly competitive market without dominant players


The Heart Valve Repair and Replacement Devices Market is witnessing significant growth, largely driven by the increasing burden of cardiovascular conditions and the demand for advanced treatment options. With nearly 55% of patients opting for less invasive solutions due to faster recovery and enhanced safety, the preference for innovative devices continues to rise. This growing focus on better clinical outcomes highlights the expanding importance of these devices in modern cardiac care.

Technological progress shaping innovations
Rapid developments in valve repair and replacement devices are transforming treatment protocols by offering improved durability, precision, and biocompatibility. Advanced systems integrated with imaging technologies are now adopted by over 40% of healthcare facilities, supporting superior performance in complex cases. These advancements are helping boost procedural success rates while ensuring long-term patient benefits.

Rising adoption of minimally invasive procedures
The movement toward minimally invasive interventions remains a central factor in market expansion. Currently, about 50% of valve-related cardiac procedures are carried out using catheter-based methods, thanks to their ability to reduce hospital stays, lower complications, and deliver faster recovery. This shift is reinforcing the demand for next-generation heart valve solutions designed to support safer and more efficient care.

Strategic alliances driving advancements
Collaboration is becoming a defining strategy, with leading companies focusing on mergers and partnerships to accelerate product innovation and broaden accessibility. More than 35% of recent device introductions and clinical improvements stem from such alliances. These partnerships not only speed up regulatory approvals but also expand the global reach of innovative solutions, ensuring greater adoption across healthcare systems.

Positive future outlook for market growth
Looking ahead, the heart valve repair and replacement devices market shows strong potential as investments in research and clinical development intensify. Nearly 45% of pipeline projects emphasize durable valve materials and personalized therapeutic solutions. With continuous innovation and a growing emphasis on efficiency, this market is positioned to play an increasingly vital role in the future of cardiovascular treatment.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Surgery
    3. Market Snapshot, By Region
  4. Global Heart Valve Repair and Replacement Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Technological Advancements
        2. Aging Population
        3. Increasing Cardiovascular Diseases
        4. Rising Awareness Programs
        5. Growing Healthcare Expenditure
      2. Restraints
        1. High Cost of Devices
        2. Stringent Regulatory Approval
        3. Limited Access to Healthcare
        4. Risk of Complications
        5. Lack of Skilled Professionals
      3. Opportunities
        1. Emerging Markets Expansion
        2. Focus on Patient Education
        3. Development of Next-Generation Devices
        4. Collaborations and Partnerships
        5. Tailored Treatment Approaches
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Heart Valve Repair and Replacement Devices Market, By Product, 2021 - 2031 (USD Million)
      1. Heart valve replacement devices
      2. Heart valve repair devices
    2. Global Heart Valve Repair and Replacement Devices Market, By Surgery, 2021 - 2031 (USD Million)
      1. Minimally invasive surgeries
      2. Transcatheter surgeries
      3. Open surgeries
    3. Global Heart Valve Repair and Replacement Devices Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Edwards Lifesciences Corporation
      2. Medtronic plc
      3. Abbott Laboratories
      4. Boston Scientific Corporation
      5. LivaNova PLC
      6. CryoLife, Inc.
      7. Lepu Medical Technology (Beijing) Co., Ltd.
      8. Micro Interventional Devices, Inc.
  7. Analyst Views
  8. Future Outlook of the Market